The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5
Stem Cell Reports · 2023
DOI: 10.1016/j.stemcr.2023.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023. Verfasst von Bonnie E J Maven und 17 weiteren Autor:innen. Beteiligte Einrichtung: Gladstone Institutes, San Francisco, CA, USA; Developmental and Stem Cell Biology PhD Program, University of California, San Francisco, San Francisco…. Hauptthemen laut MEDLINE: Transcription Factors, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, AHRQ HHS, Roddenberry Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gladstone Institutes, San Francisco, CA, USA; Developmental and Stem Cell Biology PhD Program, University of California, San Francisco, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San…
- Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
- Stowers Institute for Medical Research, Kansas City, MO, USA.
- Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA; Quantitative Biosciences Institute (QBI), University of Ca…
- Stowers Institute for Medical Research, Kansas City, MO, USA; Department of Pathology and Laboratory Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
- Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Franci…
Förderung
- NHLBI NIH HHS
- AHRQ HHS
- Roddenberry Foundation
- Vir Biotechnology
- National Institutes of Health
- Additional Ventures
- National Heart, Lung, and Blood Institute
- Japan Society for the Promotion of Science
Zitieren
APA
Maven, B. E. J., Gifford, C. A., Weilert, M., Gonzalez-Teran, B., Hüttenhain, R., Pelonero, A., Ivey, K. N., Samse-Knapp, K., Kwong, W., Gordon, D., McGregor, M., Nishino, T., Okorie, E., Rossman, S., Costa, M. W., Krogan, N. J., Zeitlinger, J., & Srivastava, D. (2023). The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.09.014
Vancouver
Maven BEJ, Gifford CA, Weilert M, Gonzalez-Teran B, Hüttenhain R, Pelonero A, et al. The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5. Stem Cell Reports. 2023. doi:10.1016/j.stemcr.2023.09.014
BibTeX
@article{Maven2023,
author = {Maven, Bonnie E J and Gifford, Casey A and Weilert, Melanie and Gonzalez-Teran, Barbara and Hüttenhain, Ruth and Pelonero, Angelo and Ivey, Kathryn N and Samse-Knapp, Kaitlen and Kwong, Wesley and Gordon, David and McGregor, Michael and Nishino, Tomohiro and Okorie, Eyuche and Rossman, Sage and Costa, Mauro W and Krogan, Nevan J and Zeitlinger, Julia and Srivastava, Deepak},
title = {The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5},
journal = {Stem Cell Reports},
year = {2023},
doi = {10.1016/j.stemcr.2023.09.014}
}
EUVIMED